0001441844-11-000028.txt : 20110706
0001441844-11-000028.hdr.sgml : 20110706
20110706185559
ACCESSION NUMBER: 0001441844-11-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110701
FILED AS OF DATE: 20110706
DATE AS OF CHANGE: 20110706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ISRAEL ROBERT J
CENTRAL INDEX KEY: 0001250274
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23143
FILM NUMBER: 11954611
MAIL ADDRESS:
STREET 1: 50 OXFORD DR
CITY: MONTEBELLE
STATE: NY
ZIP: 10901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000835887
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133379479
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9147892800
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0303
4
2011-07-01
0
0000835887
PROGENICS PHARMACEUTICALS INC
PGNX
0001250274
ISRAEL ROBERT J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
Senior VP Medical Affairs
Common Stock
2011-07-01
4
M
0
1000
5.33
A
37151
D
Common Stock
2011-07-01
4
S
0
1000
7.205
D
36151
D
Common Stock
2011-07-01
4
M
0
8322
5.46
A
44773
D
Common Stock
2011-07-01
4
F
0
6930
7.4
D
37843
D
ESPP (right to buy)
5.46
2011-07-01
4
M
0
8322
0
D
2011-07-01
2011-07-01
Common Stock
8322
0
D
Non-Qualified Stock Option (right to buy)
5.33
2011-07-01
4
M
0
1000
0
D
2010-07-01
2019-07-01
Common Stock
1000
37000
D
Non-Qualified Stock Option (right to buy)
7.4
2011-07-01
4
A
0
70000
0
A
2012-07-01
2021-07-01
Common Stock
70000
70000
D
The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer.
This transaction was executed in multiple trades at prices ranging from $7.02 to $7.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
Includes shares of common stock acquired from the non-reportable exercise of a Grant under the Qualified Employee Stock Purchase Plan.
Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. The number of shares acquired upon exercise is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date.
The stock options become exercisable in three equal annual installments, commencing one year from the grant date.
By: Robert A. McKinney For: Robert J. Israel
2011-07-06